Trials / Completed
CompletedNCT02217228
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
A Randomized, Prospective, Multicenter, Controlled Study With Blinded Assessment to Determine the Safety and Effectiveness of the Sebacia Acne Treatment System in the Treatment of Inflammatory Acne Vulgaris
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 394 (actual)
- Sponsor
- Sebacia, Inc. · Industry
- Sex
- All
- Age
- 15 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, randomized multicenter study to examine the safety and effectiveness of Sebacia microparticles with or without laser in the treatment of moderate to moderately-severe inflammatory acne vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sebacia microparticles and laser | |
| DEVICE | Vehicle suspension and laser | |
| DEVICE | Sebacia microparticles without laser |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-08-15
- Last updated
- 2017-09-18
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02217228. Inclusion in this directory is not an endorsement.